Webskyne
Webskyne
LOGIN
← Back to journal

23 May 202622 min read

The Week That Was: AI Is Eating the Stack, EVs Reinvent the Drive, and Biotech Goes Big on Cells

It has been one of the most consequential weeks in technology in years — and yet, most people missed it because the headline noise made the signal invisible. Three separate but deeply interconnected revolutions are accelerating in parallel: the explosion of new AI model providers and an arms race over compute infrastructure, a full-blown reinvention of the electric and autonomous vehicle category, and a quiet but extraordinary biotech renaissance based on next-generation cellular therapies. In this week's edition, we walk through the most significant and underreported developments across all three tracks — no politics, no clickbait, just substance from the sources that actually matter.

TechnologyAIArtificial IntelligenceMachine LearningEVElectric VehiclesBiotechCell TherapyNvidia
The Week That Was: AI Is Eating the Stack, EVs Reinvent the Drive, and Biotech Goes Big on Cells

The Week That Was: AI Is Eating the Stack, EVs Reinvent the Drive, and Biotech Goes Big on Cells


The AI Arms Race That No One Is Talking About

If you opened any major technology publication this week, you would have found the same handful of stories endlessly recycled: executive-gated AI regulation debates, another round of warnings about existential risk, and opinions on whether another chatbot had finally crossed a fictional line. But behind all that noise, three genuinely transformative developments were happening — and they were barely covered.

The first story is the beginning of real fragmentation and consolidation at the highest level of the AI model stack. For most of the past two years, the conversation has been artificially simplified to "OpenAI versus Google versus Anthropic versus xAI." That framing was always wrong, but it is now actively misleading. The real dynamics do not pit these providers against each other — they pit them against their own infrastructure suppliers and against the calculation that the only way to win is to own as much of the stack as possible.

The second story is that AI cost curves and diffusion velocity have reached a tipping point where generative AI is no longer just a product feature — it is the foundation on which new products are being built. The ChatGPT integration for Microsoft PowerPoint that dropped this week is not a minor interface addition. It is a marker. PowerPoint — one of the most entrenched pieces of software in human history — is now being rearchitected around an AI engine. That is potentially a bigger moment than any model release.

The third story — more on this later — is that one of AI's most important safety figures is walking away from the company that has nominally led the model safety discourse, and there is virtually no clear consensus on what it means.

But before we get to personnel, we have to talk about the machines running all this intelligence — and the stakes in that fight just went through the roof.

Anthropic, Microsoft, and the Compute Consolidation Problem

Anthropic, the company behind Claude, has been one of the more carefully managed players in the AI model space — known and trusted for its positional safety work, its measured pace, and its philosophical stance against racing ahead without guardrails. This week, two stories landed on the same lap that complicate that picture significantly.

On Thursday, it was reported that Anthropic is in early talks to rent Microsoft Azure servers running Microsoft's own AI chips — Maia 200 — in order to expand the compute available to Claude. That announcement comes just weeks after a massive $15-billion-per-year deal was announced between Anthropic and SpaceX to support Claude's growing workload on SpaceX's Colossus supercomputing cluster. If a $15-billion-per-year deal is apparently insufficient to keep up with demand for Claude inference and training, that says something very specific about how fast model capability is consuming compute capacity — and it also makes clear why Anthropic would want to diversify its suppliers.

The problem with the narrative that this is just a long-term corporate negotiation is that it conceals a structural change in the market. Less than two years ago, the dominant story was "Nvidia has a monopoly on AI chips, and that is unhealthy." The second iteration was "AMD, Intel, and the hyperscalers are building their own chips to break the monopoly." The current story appears to be that even if you write a $15-billion check to one supplier and negotiate a second arrangement with another, the physics of model scaling means no single infrastructure deal is large enough — and fast enough — to sustain the product cadence that current AI companies have committed to in their go-to-market narratives.

The second Anthropic story is equally interesting for a different reason. The company rolled out a significant expansion of Project Glasswing this week. Project Glasswing is Anthropic's internal security-testing system — what they have been calling a "threat model builder" — which is designed to probe Claude for adversarial input handling and model behavior under stress. The announcement marks the first time external customers who meet a qualifying threshold can access certain components of the framework. What is most interesting here is not the tool itself but what it signals: Anthropic is beginning to treat security as a service capability rather than an internal process. In a world where AI systems are being deployed in healthcare, legal, and government contexts, that is a legitimate market signal — and a competitive moat for Anthropic if they can defend and extend it.

OpenAI Is Bleeding Talent. Here Is What It Means.

On Thursday, Aleksandr Madry — one of the most respected AI safety researchers in the world — announced he is leaving OpenAI. If you have followed AI policy and model safety discussions over the past five years, Madry's name will be familiar. He joined OpenAI at the height of the company's most publicly visible safety period and held the role of Head of Preparedness, the role nominally responsible for asking "what happens if this model is wildly more capable than we anticipated?" before releasing new systems. In 2024, amid what were reported as internal tensions over AI safety priorities, Madry was reassigned to a role focused on AI reasoning instead of safety.

His departure, announced in a short post, frames the new work as being "centered on AI's impact on the economy." That phrasing is hilariously, tragically telling: safety engineers are leaving the companies building potentially autonomous systems to study economic disruption instead, because the internal structures available to them have been reorganized to prioritize deployment over the kind of defensive research they were trained to do.

What this means for the broader field is worth stating plainly. OpenAI has repeatedly attempted to frame its public commitment to AI safety as a structural feature of the company rather than a voluntary posture. Personnel churn in safety-focused roles — in the absence of any public explanation of what changed internally — undermines that claim. More to the point, it leaves one of the most valuable AI models in existence with a smaller safety voice inside the rooms where its next versions are being planned.

This is not an anti-Madry statement. Madry's work has been genuinely excellent. The question is what OpenAI's structural commitment to safety looks like when its most prominent safety leadership exits quietly and without fanfare. The fact that the announcement was buried in the same news cycle as the company's most significant competitor's infrastructure announcements should itself tell you something about how the AI model market is currently prioritizing news.

Nvidia's $75 Billion Quarter and the Silicon Stack Effect

Nvidia reported first-quarter fiscal 2027 revenue of $81.6 billion — a company reported in a single quarter. The data center segment alone accounted for $75.2 billion, up 92 percent from the same quarter a year prior. This is a number that defies easy comprehension. It is larger than the annual revenue of most Fortune 500 companies. And it is driven almost entirely by demand for AI-accelerated compute infrastructure.

The implications of that trillion-dollar-at-run-rate AI compute market go far beyond Nvidia's own share price, important as that is. Every other AI model provider — from Anthropic to xAI to Google DeepMind — is either already dependent on Nvidia's silicon or making frantic efforts to escape that dependence. Google has been designing its own TPU chips for years and increasingly runs its own inference on those. Microsoft has its Maia and Cobalt lines. Amazon is betting heavily on its Inferentia and Trainium chips. But none of those alternatives — spectacular as the engineering effort behind them is — are keeping pace with the speed at which Nvidia is improving its own platforms, particularly at Blackwell-class inference workloads.

The second-order effect of compute dominance is that the entire software stack above the silicon — operating systems, model runtimes, training frameworks — has been designed by Nvidia and optimized for Nvidia. If you are a model company that wants to remain independent of Nvidia's software ecosystem, the migration cost is enormous. That is exactly what makes the Anthropic-Microsoft chip talks so interesting: Anthropic may actually have a path to diversified, non-Nvidia compute that preserves model performance thanks to Maia 200 being explicitly designed to handle Claude-family model inference workloads. If that works, it legitimately shifts some of Nvidia's position.

For now, however, the numbers do not lie. The world has decided — consciously or otherwise — to build its AI future on top of Nvidia silicon. That is a situation regulators and national security communities around the world have not yet meaningfully absorbed.

Generative AI Leaks Into Every Consumer Interface

Every few weeks, there is an arrival that seems modest but obeys an important pattern: AI crosses a threshold into a piece of software that was previously considered untouchable by automation. This week that threshold event was the ChatGPT integration for Microsoft PowerPoint, which is now available in beta to qualifying ChatGPT plans.

The integration works like this: you open PowerPoint, a ChatGPT sidebar appears within the application, and using natural language prompts you can generate complete slide decks from scratch, edit and reshape existing presentations, pull in content from documents and images, and animate. It traverses the same pathway as the existing ChatGPT-Excel integration, which means the architecture is a demonstrated existing platform, not a speculative demo. You do not need to switch contexts, copy-paste between windows, or imagine how an AI presentation might look — you are creating it directly in the software you already use.

The significance of this particular integration is not that PowerPoint finally has AI. It is that PowerPoint is the software equivalent of tectonic plate: it is the bottom of the office productivity layer, used by everyone from McKinsey consultants to high school students to budget managers. Making a permanent structural change to PowerPoint's interaction model — moving it from a document-centric authoring tool to an AI-orchestrated design environment — is the kind of change that recalibrates how millions of people approach core professional tasks.

On the advertising and social side, CapCut — the video editing tool owned by ByteDance — announced that its editing capabilities are coming directly into the Google Gemini app. Users will be able to edit images and videos "directly within the Gemini app using CapCut's editing capabilities," according to the official announcement. This is a second vector in exactly the same pattern: AI interfaces are not competing with creative tools — they are absorbing them, making the AI the operating system through which the creative work happens.

Meanwhile, Spotify announced that a new feature will soon allow authors to generate AI audio versions of their books directly within the Spotify platform. The pattern is unmistakable. Three different companies on three completely different verticals — productivity software, video editing, and audiobook production — are converging on the same structural transformation: AI is not the feature of an application, it is the application's primary interface, and every other function of the software routes through it.

The EV Revolution Gets Very Interesting, Very Fast

Despite persistent economic headwinds — tariffs, regulatory reversals in major markets, and analysts who have been predicting a "cooling EV market" for two years running — the automotive sector's transformation into a software- and electrification-first category has intensified, not decelerated. What is most remarkable about the current wave of EV announcements is not the technical complexity of the vehicles — it is how fast the lineup has diversified across prices, performance tiers, and driving profiles.

The beginning of the signal worth paying attention to on this front is Volkswagen's ID. Polo GTI — the first all-electric vehicle in the GTI brand's fifty-year history. Teased in concept in 2023 and now formally introduced with pricing of "just under" €39,000 in Germany, the ID. Polo GTI demonstrates something that mass-market EV adoption most clearly needed to demonstrate: that performance sub-brands can go electric without diluting their identity. The 52 kWh battery delivers 263 miles of range, and a 0–100 km/h time of 6.8 seconds matches what a modern hot hatch is expected to deliver. The car answers a question that EV skeptics have been asking since 2020: can a vehicle that is good at the things that make a hot hatch beloved be electric? The answer is now yes — and it comes in at a working family's budget point.

Over at the ultra-luxury end of the market, Audi pulled off a genuinely impressive piece of regulatory and engineering strategy with the US arrival of its Matrix LED headlights, which will first appear on the Q9 and SQ9 SUVs. The technology — which debuted in Europe in 2013 — uses the vehicle's front-facing cameras to sculpt the light beam in real time, actively avoiding dazzling oncoming drivers while improving beam reach for the driver's benefit simultaneously. Regulatory frameworks in the United States had effectively made that technology illegal for export market vehicles for a decade, but a 2022 NHTSA rule change cleared the path, and Audi is the first manufacturer to ship a production vehicle with the technology in the US market. The engineering, regulatory, and market timing of that rollout is a masterclass in automotive product management.

German Engineering's Last Stand — and Smart Pivot

BMW's decision to discontinue the iX in the United States markets and redirect its EV investment toward the Neue Klasse platform is, on its surface, a retreat. Read that way, it would confirm the narrative that American EV policy shifts — and the withdrawal of federal incentives for EV purchases — are undoing the investment rationale that led premium European manufacturers to bring electric models to the US in the first place. That interpretation is not wrong, but it is incomplete.

The part of this story that commentators missed is what BMW is replacing the iX with: the iX3, which arrives on the Neue Klasse platform and is positioned to arrive within months, not years. The Neue Klasse architecture is the backbone of BMW's electric future for the next generation, not a Kafkaesque financial engineering name applied to a refresh. The iX3 on Neue Klasse will arrive with a range significantly higher than what the outgoing iX shipped with, a cost basis that BMW claims is materially lower, and a fully redesigned interior electronics architecture that traditionalists and software-forward drivers will find genuinely different.

The broader context here is that the United States is, as one economist commentator put it in a New York Times column, regressing as an EV market against the rest of the industrialized world. Detroit stopped producing affordable compact electric vehicles about twenty years ago; the "econobox" is essentially dead in American mass-market new car retail. Among the proposed responses is opening US markets to low-cost electric vehicles from China. Whether or not that policy path is adopted at scale, the structural gap between the vehicle selection available to US consumers at affordable price points and the much wider, more competitive, and genuinely cheaper EV range available in European and Chinese markets is real and widening. It may not be a consumer-facing story in the same way a new hot-hatch release is — but its long-term economic impact on the US auto market is enormous.

Tesla Robotaxi Grows Up, Mercedes Shuts Down a Bridge

On the same week that Tesla released an Android version of its Robotaxi app — eight months after the iOS version shipped — the service was quietly expanding into Houston and Dallas. The expansion is notable, but what is genuinely unusual about the Tesla Robotaxi news is the speed at which customer-facing AI driving systems are accumulating real operational deployment, not hype cycles. Early reports suggest the actual number of Robotaxi-capable vehicles on the road remains relatively small, meaning the "fleet" narrative Tesla began building remains largely aspirational. But the software is there, the interface is polished, and the service is now available on both major mobile platforms.

In news that could only happen in 2026, Mercedes-Benz drove a concept AMG GT four-door coupe electric vehicle up and down Los Angeles's 6th Street Bridge at sunset during a product launch event attended by six hundred people — performing burnouts with Brad Pitt and George Russell as passengers — while Blink-182 played a thirty-minute set that included a certain category of jokes that would probably have caused a very serious public relations team to consider resignation. The car itself — the Mercedes-AMG GT four-door electric coupe — is precisely the kind of vehicle that old-guard automotive journalists once sneered at EVs for not being able to be: high horsepower, high drama, high production values. It is also, by every metric that matters, a genuine electric performance vehicle — and it exists right now, not in a rendering.

Meanwhile, a quieter operational reality arrived the same week: Mercedes-Benz recalled approximately 144,000 vehicles built between 2024 and 2026 — covering the AMG GT, C-Class, E-Class, SL-Class, CLE-Class, and GLC-Class — because defective software was occasionally triggering a system reset that would cause the instrument cluster display to go blank temporarily. For most cars, a temporary display reset is an inconvenience. For a vehicle with a 1.4-meter-wide hyperscreen architecture that doubles as the primary instrument cluster and navigation interface, it is a serious driving distraction that regulators at the NHTSA considered worthy of a formal recall. The point is not to single out Mercedes — recalls exist for exactly this — it is to observe that as vehicles become full-screen, software-driven platforms, the failure modes and the regulatory responses to them are fundamentally different in kind than they were a decade ago.

Biotech's Cell Therapy Moment Has Arrived

If you have been watching biotech over the past several years, a quiet but unmistakable consolidation has been happening in cell therapy — the genetic modification of human immune cells to fight cancer and other diseases. CAR-T cell therapies, the most established form of the technology, have for years been prohibitively expensive — sometimes costing more than $400,000 per treatment course — and primarily approved for blood cancers rather than solid tumors. A single company, Novartis, shipped a product into the market in 2022 built around its T-Charge platform that has been working quietly to demonstrate that the economics and indications of cell therapy can expand meaningfully beyond blood cancers.

This week, Fierce Biotech confirmed that Novartis's T-Charge platform — after more than four years of clinical development — has established a credible position in the treatments pipeline for what the biotech community calls "cell therapy's next billion-dollar opportunity": solid tumor cancers. The time gap between achieving phase-one proof of concept and actual commercial-stage approval for indications beyond blood cancers is finally collapsing, and the companies that filed first and fastest are the ones positioned to own that category.

The economics story here is genuinely worth following. Cell therapies are expensive to manufacture because they are, by definition, customized biological products — each dose is a living medicine built from a patient's own cells, modified ex vivo, then reintroduced to fight disease. The manufacturing cost per dose is traditionally high and scalable only with difficulty. The companies that figure out how to reduce that cost structure while improving performance are the ones that will open up access to billions of patients worldwide — a genuinely historic public health opportunity. The T-Charge platform appears to be one of those answers.

Mapp and the Ebola Response — Antibodies Go Mainstream

In a piece of hard-to-find biotech news that probably got lost beneath bigger headlines, Mapp Biopharmaceutical recently shipped doses of an experimental Ebola antibody treatment intended for use in people at high risk of exposure. The shipment represents one of those rare moments when government pharmaceutical preparedness infrastructure actually arrives where it is needed before an outbreak starts — not during or after.

What makes this story worth tracking outside of epidemiological interest is the underlying technology shift. For decades, treatment for viral diseases like Ebola has faced a fundamental problem: drugs work by interfering with biological processes in infected cells, but early intervention on a severe viral infection often arrives too late for small-molecule drugs to be effective. Broadly neutralizing monoclonal antibodies — engineered immunoglobulins designed to attach to a virus and prevent it from infecting cells — are fundamentally different as a medicine class. They scale and stockpile more readily than many traditional drug types, meaning the manufacturing and logistics infrastructure that ships experimental Ebola antibody treatments today is structurally similar to the infrastructure that will handle the next major respiratory pathogen response, provided the technology maturation trajectory holds.

The Week's Thread: Where All Three Revolutions Meet

The most intellectually and economically interesting question coming out of this week's news is not about AI models, or EV platforms, or cell therapies individually. It is what happens when all three of these categories begin interacting.

AI is being used by biotech companies to predict protein structures and accelerate drug discovery — virtually every major pharmaceutical company's research pipeline is now materially accelerated by machine learning. AI is being used by EV manufacturers to optimize battery chemistry, model vehicle aerodynamics, and train autonomous driving systems. The compute that is powering Nvidia's $75-billion data center quarter is, quite directly, powering both revolutions simultaneously.

The Anthropic-Microsoft chip talks — in this context — are about an entirely different kind of infrastructure investment than what is happening with Nvidia's GPUs. Anthropic is effectively describing a situation in which the company's AI models, when applied to biotech research and vehicle modeling, might be consuming so much compute that no single supplier — even a co-equity partner like SpaceX — can provide the required capacity. That is a story about how fast the physics of AI compute are compounding, not about which AI company will "win" in some abstract consumer benchmark.

The xAI-to-SpaceXAI reorganization completes a circle that observers have been watching for months: SpaceX has become a compute infrastructure company; xAI has become the AI model builder. Combining them creates a vertically integrated AI platform — SpaceX's launch and satellite infrastructure, Colossus supercomputing, and xAI's model capacity — under one corporate umbrella. That stacks up directly against a vertically integrated Amazon, a Google that owns its own TPUs and hyperscalers, and an Anthropic in talks to diversify away from its primary compute supplier. The competitive architecture of AI in 2026 is not three companies in a race. It is five vertically integrated compute-AI platforms jockeying for control of the entire stack above and below the model layer.

What to Watch Next

The Anthropic compute logic

Watch not just whether Anthropic finalizes the Microsoft chip deal, but whether Claude's next model launch shows measurable cost improvements at inference time if Maia 200 is part of the serving infrastructure. That is the clearest outside-the-company signal for whether the deal is about cost structure as well as capacity.

OpenAI's safety leadership succession

Madry's departure creates a vacancy. Watch who fills it and what that person's background is. If the new safety lead is primarily a deployment and product executive, the signal is clear. If it is someone with significant interpretability and risk-assessment credentials, the inoculation against the most concerning concerns will be partially restored.

The EV mass-market price inflection point

The ID. Polo GTI at just under 39,000 euros is the first credible answer to the "EV premium" that has kept many households from converting. If other mainstream manufacturers follow with genuinely competitive pricing at that tier through 2026, the inflection point in total EV market share will be visible in 2027.

Biotech cell therapy manufacturing costs

The companies solving the manufacturing cost problem for cell therapies are quietly positioned to create what may be the single most valuable franchise in the history of pharmaceutical markets — once treatments become accessible at costs broader health systems can absorb. Watch that manufacturing cost trajectory closely; it is the proxy for access.


Conclusion: The Real Transformation Is Structural, Not Narrative

The biggest mistake readers make when skimming technology news cycles — and this is true across AI, EVs, and biotech simultaneously — is waiting for a product launch or a model release to declare the story "real." The actual transformation is happening structurally: in the compute supply chain, in the manufacturing cost equations of biological products, and in the personnel and governance decisions inside the companies building the most consequential new technology.

Anthropic expanding its security tooling externally tells you something about where the AI safety product market is going. Administrative departures at OpenAI expose where the internal priority is — and it is not safety-first anymore. Nvidia's $75-billion quarter tells you the magnitude of the compute investment orchestrating everything else. VW shipping an electric GTI under 40,000 euros tells you where mass EV adoption actually needs to land for it to matter at scale. Novartis's T-Charge platform data in solid tumor indications tells you where cell therapy's economic impact is about to accelerate.

The technology stories this week are not competing events for your attention. They are layers of the same process unfolding across three super-categories at once. The companies that understand they compete on the same stack — not just within a single category — are the ones that will define the decade ahead.

Sources: The Verge (Artificial Intelligence, Science, Cars verticals); Fierce Biotech; Stat News Biotech.

Related Posts

The Week That Was: AI Provider Deals Hit $15B, EVs Get Competitive Again, and Biotech's Quiet Revolution
Technology

The Week That Was: AI Provider Deals Hit $15B, EVs Get Competitive Again, and Biotech's Quiet Revolution

Anthropic inks a $15-billion annual AI compute deal with SpaceX while Nvidia's data center revenue surges 92%. Tesla's Cybercab is officially the most efficient production EV ever built — by a large margin. Kia kills its cheapest gas car to make room for a replacement EV. In biotech, Novartis revisits its CAR-T foundation four years after T-Charge debuted, and the whole field has changed. This week showed why 2026 is shaping up as the year the Silicon Valley AI build-out, the EV revolution, and precision medicine all come of age — simultaneously.

From Monolith to Microservices: How a Legacy E-Commerce Platform Cut Deploy Times by 87%
Technology

From Monolith to Microservices: How a Legacy E-Commerce Platform Cut Deploy Times by 87%

When Meridian Retail, a fast-growing apparel e-commerce brand serving over 2.4 million monthly active customers, found its flagship storefront collapsing under Black Friday traffic for the third year running, the company's leadership realised their eight-year-old monolithic architecture had become a genuine business liability. Catalogue releases were breaking checkout sessions, analytics queries were timing out during flash sales, and individual developer teams were waiting two to three weeks between pull-request approval and production deployment. This case study traces the full eighteen-month transformation from PHP-based monolith to a Node.js- and Go-backed event-driven microservices platform, detailing the technical decisions, the trade-offs made under pressure, and the measurable outcomes that emerged — including an 87% reduction in deploy cycle time, a 40% improvement in page-load performance, and 99.97% uptime sustained through peak traffic windows that exceed 150,000 concurrent users.

The Week That Was: AI Chips Bill, Autonomous Cars Go for a Swim, and Biotech's Quiet Carnage
Technology

The Week That Was: AI Chips Bill, Autonomous Cars Go for a Swim, and Biotech's Quiet Carnage

This week in technology reads like a script from a near-future thriller — and the writing is increasingly difficult to distinguish from reality. Nvidia posted record-breaking data center revenue even as chip prices are debated; Anthropic is reportedly profitable for the first time while drafting security tools for a Claude version few have seen; Tesla's Full Self-Driving landed in China on the same day a White House AI executive order was postponed. Meanwhile autonomous vehicles kept steering straight into floodwater, CAR-T therapies are being overhauled with a next-generation platform, and an AI-powered voice assistant is shipping as standard equipment on a mainstream EV. The signals are noisy but the trends are impossible to miss. This roundup pulls apart what actually happened across the three sectors that matter most — AI infrastructure and models, connected and autonomous transportation, and the biotech pipeline — without the editorializing.